MedTrace Logo

The Effect of Oxytocin on Placebo Analgesia: an Experimental Study in Healthy Volunteers

NCT01886014 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2013-06-26

No results posted yet for this study

Summary

Placebo responses contribute to medical treatment outcome. The purpose of this study is to determine whether a single intranasal application of oxytocin can increase the placebo response in an experimental model of placebo analgesia in healthy volunteers.

Conditions

  • Mechanisms and Modulators of Placebo Analgesia in Healthy Volunteers

Interventions

DRUG

Oxytocin

OTHER

placebo

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Ulrike Bingel, MD, PhD · Department of Neurology, University Medical Center Hamburg-Eppendorf

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01886014 on ClinicalTrials.gov